These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 28100357)

  • 21. Characterization of lung function impairment in adults with bronchiectasis.
    Guan WJ; Gao YH; Xu G; Lin ZY; Tang Y; Li HM; Lin ZM; Zheng JP; Chen RC; Zhong NS
    PLoS One; 2014; 9(11):e113373. PubMed ID: 25405614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of bronchiectasis in severe uncontrolled asthma.
    Dimakou K; Gousiou A; Toumbis M; Kaponi M; Chrysikos S; Thanos L; Triantafillidou C
    Clin Respir J; 2018 Mar; 12(3):1212-1218. PubMed ID: 28544140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Objective Assessment of Cough Frequency in Bronchiectasis.
    Spinou A; Lee KK; Sinha A; Elston C; Loebinger MR; Wilson R; Chung KF; Yousaf N; Pavord ID; Matos S; Garrod R; Birring SS
    Lung; 2017 Oct; 195(5):575-585. PubMed ID: 28707107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic-resistant
    Gao YH; Guan WJ; Zhu YN; Chen RC; Zhang GJ
    Int J Chron Obstruct Pulmon Dis; 2018; 13():237-246. PubMed ID: 29386892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence of pldA and exoU in mucoid Pseudomonas aeruginosa is associated with high risk of exacerbations in non-cystic fibrosis bronchiectasis patients.
    Luo RG; Miao XY; Luo LL; Mao B; Yu FY; Xu JF
    Clin Microbiol Infect; 2019 May; 25(5):601-606. PubMed ID: 30036669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exacerbations and Pseudomonas aeruginosa colonization are associated with altered lung structure and function in primary ciliary dyskinesia.
    Piatti G; De Santi MM; Farolfi A; Zuccotti GV; D'Auria E; Patria MF; Torretta S; Consonni D; Ambrosetti U
    BMC Pediatr; 2020 Apr; 20(1):158. PubMed ID: 32284045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of non-invasive modalities for assessing inflammation in patients with non-cystic fibrosis bronchiectasis.
    Tsikrika S; Dimakou K; Papaioannou AI; Hillas G; Thanos L; Kostikas K; Loukides S; Papiris S; Koulouris N; Bakakos P
    Cytokine; 2017 Nov; 99():281-286. PubMed ID: 28863927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of Disease in Patients with Middle-Lobe Predominant Bronchiectasis.
    McDonnell MJ; Ahmed M; Das J; O'Mahony M; Breen D; O'Regan A; Gilmartin JJ; Bruzzi J; Rutherford RM
    Respiration; 2017; 93(6):406-414. PubMed ID: 28423372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of effects of bronchiectasis on bronchial artery diameter with multidetector computed tomography.
    Kosar M; Kurt A; Keskin S; Keskin Z; Arslan H
    Acta Radiol; 2014 Mar; 55(2):171-8. PubMed ID: 23897305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
    Bilton D; Henig N; Morrissey B; Gotfried M
    Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The bronchiectasis severity index. An international derivation and validation study.
    Chalmers JD; Goeminne P; Aliberti S; McDonnell MJ; Lonni S; Davidson J; Poppelwell L; Salih W; Pesci A; Dupont LJ; Fardon TC; De Soyza A; Hill AT
    Am J Respir Crit Care Med; 2014 Mar; 189(5):576-85. PubMed ID: 24328736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Multiple Faces of Non-Cystic Fibrosis Bronchiectasis. A Cluster Analysis Approach.
    Martínez-García MÁ; Vendrell M; Girón R; Máiz-Carro L; de la Rosa Carrillo D; de Gracia J; Olveira C
    Ann Am Thorac Soc; 2016 Sep; 13(9):1468-75. PubMed ID: 27348199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.
    Serisier DJ; Martin ML; McGuckin MA; Lourie R; Chen AC; Brain B; Biga S; Schlebusch S; Dash P; Bowler SD
    JAMA; 2013 Mar; 309(12):1260-7. PubMed ID: 23532242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study.
    Dicker AJ; Lonergan M; Keir HR; Smith AH; Pollock J; Finch S; Cassidy AJ; Huang JTJ; Chalmers JD
    Lancet Respir Med; 2021 Aug; 9(8):885-896. PubMed ID: 33961805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemoptysis as the presenting manifestation of bronchiectasis-associated hospitalization in Korea.
    Seo H; Cha SI; Park J; Lim JK; Park JE; Choi SH; Lee YH; Yoo SS; Lee SY; Lee J; Kim CH; Park JY
    J Thorac Dis; 2023 Jul; 15(7):3636-3645. PubMed ID: 37559598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arterial stiffness in adults with steady-state bronchiectasis: association with clinical indices and disease severity.
    Gao YH; Cui JJ; Wang LY; Yin KQ; Wang L; Zhang GJ; Liu SX
    Respir Res; 2018 May; 19(1):86. PubMed ID: 29743118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defining pulmonary exacerbation in children with non-cystic fibrosis bronchiectasis.
    Kapur N; Masters IB; Morris PS; Galligan J; Ware R; Chang AB
    Pediatr Pulmonol; 2012 Jan; 47(1):68-75. PubMed ID: 21830316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting high risk of exacerbations in bronchiectasis: the E-FACED score.
    Martinez-Garcia MA; Athanazio RA; Girón R; Máiz-Carro L; de la Rosa D; Olveira C; de Gracia J; Vendrell M; Prados-Sánchez C; Gramblicka G; Corso Pereira M; Lundgren FL; Fernandes De Figueiredo M; Arancibia F; Rached SZ
    Int J Chron Obstruct Pulmon Dis; 2017; 12():275-284. PubMed ID: 28182132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationships between high-resolution computed tomography, lung function and bacteriology in stable bronchiectasis.
    Lee JH; Kim YK; Kwag HJ; Chang JH
    J Korean Med Sci; 2004 Feb; 19(1):62-8. PubMed ID: 14966343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unsupervised learning technique identifies bronchiectasis phenotypes with distinct clinical characteristics.
    Guan WJ; Jiang M; Gao YH; Li HM; Xu G; Zheng JP; Chen RC; Zhong NS
    Int J Tuberc Lung Dis; 2016 Mar; 20(3):402-10. PubMed ID: 27046724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.